Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Humira
Pharma
AbbVie shrugs off new J&J competition for fast-growing Skyrizi
Immunology med Skyrizi charted sales growth of 30.9% over 2026's quarter, bringing home $4.48 billion as AbbVie's top earner.
Zoey Becker
Apr 29, 2026 2:53pm
AbbVie launches ‘PSO Done’ psoriasis campaign
Apr 20, 2026 8:03am
AbbVie touts Skyrizi, Rinvoq prowess amid J&J IBD competition
Feb 4, 2026 2:52pm
AbbVie locks in US pricing deal as it pledges $100B investment
Jan 13, 2026 9:15am
Inside the turning tides of the US biosimilar market
Jan 8, 2026 9:00am
AbbVie increases 2025 revenue projection again, now at $60.9B
Oct 31, 2025 12:14pm
